Epstein Secrets

ment to illegally procure research." Rubio Doubts IC Global Threats Hearing Will Happen This Year. Politico (7/28, Matishak, 4.29M) reports acting Senate Intelligence Chair Marco Rubio (R-FL) "raised doubts Tuesday that the panel will hold a public session on global threats facing the US this year, citing increas

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

en This Year. Politico <https://www.politico.com/news/2020/07/28/rubio-intelligence-hearing-security-385091> (7/28, Matishak, 4.29M) reports acting Senate Intelligence Chair Marco Rubio (R-FL) "raised doubts Tuesday that the panel will hold a public session on global threats facing the US this year, citing increase

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

nment to illegally procure research." Rubio Doubts IC Global Threats Hearing Will Happen This Year. Politico (7/28, Matishak, 4.29M) reports acting Senate Intelligence Chair Marco Rubio (R-FL) "raised doubts Tuesday that the panel will hold a public session on global threats facing the US this year, citing increas

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

nment to illegally procure research." Rubio Doubts IC Global Threats Hearing Will Happen This Year. Politico (7/28, Matishak, 4.29M) reports acting Senate Intelligence Chair Marco Rubio (R-FL) "raised doubts Tuesday that the panel will hold a public session on global threats facing the US this year, citing increas

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U